Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for curing cardio-cerebralvascular diseases and production method thereof

A cardiovascular and cerebrovascular disease, cardiovascular and cerebrovascular technology, applied in the direction of cardiovascular system diseases, drug combination, capsule delivery, etc., can solve the problem that the repair of damaged cell membrane of cardiovascular and cerebrovascular can not produce direct effect, cannot convert energy and eliminate vascular deposits , treatment of cardiovascular and cerebrovascular diseases without special effects, etc.

Inactive Publication Date: 2008-10-22
林华型
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

With the development of cardiovascular and cerebrovascular pharmacy, many new drugs have emerged in recent years, which have certain limitations in the treatment of heart diseases and nutritional value, such as adenosine, fructose 1.6-diphosphate, etc., but these drugs cannot convert energy and eliminate The deposits in the blood vessels can not have a direct effect on the cardiovascular and cerebrovascular and myocardial functions or the repair of damaged cell membranes. Therefore, there is currently no effective way to treat cardiovascular and cerebrovascular diseases in Chinese medicine.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for curing cardio-cerebralvascular diseases and production method thereof
  • Medicine for curing cardio-cerebralvascular diseases and production method thereof
  • Medicine for curing cardio-cerebralvascular diseases and production method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] coenzyme Q 10 (CoQ 10 )10%

[0050] Vitamin E (VE) 40%

[0051] Soy Lecithin (PC) 50%

[0052] production method:

[0053] coenzyme Q 10 , vitamin E, soybean lecithin and other raw materials are finely powdered, volatilized and mixed to prepare soft capsules.

Embodiment 2

[0055] coenzyme Q 10 (CoQ 10 ) 20%

[0056] Vitamin E (VE) 20%

[0057] Soy Lecithin (PC) 60%

[0058] Production method: Same as above example

Embodiment 3

[0060] coenzyme Q 10 (CoQ 10 ) 30%

[0061] Vitamin E (VE) 30%

[0062] Soy Lecithin (PC) 40%

[0063] Production method: Same as above example.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating cardiocerebrovascular diseases, which is mainly prepared by the following raw materials: coenzyme Q10 (CoQ10), Vitamin E (VE) and soybean lecithin (PC). The medicine is widely used for treating coronary heart disease, cardiac failure, arrhythmia, rheumatic heart disease, viral myocarditis, blood supply deficiency, high blood pressure, and other cardiocerebrovascular diseases and periodontitis resulted from gingival atrophy and also can be used as adjuvant therapy for acute and chronic viral hepatitis and cancer, which also has the efficacies of decreasing blood lipid, lowering cholesterol, regulating internal secretion, eliminating climacteric syndrome, resisting aging, preventing senile dementia, etc. In addition, the invention also discloses a production method for preparing the medicine for treating cardiocerebrovascular diseases with semisynthetic raw material.

Description

technical field [0001] The invention relates to a medicine for treating cardiovascular and cerebrovascular diseases, and a production method of the medicine for treating cardiovascular and cerebrovascular diseases made from semi-synthetic raw materials. Background technique [0002] Cardiovascular and cerebrovascular diseases caused by ischemia and hypoxia, such as coronary heart disease, coronary artery stenosis, blockage or spasm caused by coronary atherosclerosis, so that the myocardium cannot get enough blood oxygen, leading to myocardial cell aging and damage, cause heart disease and even death. Another example is myocardial infarction due to coronary artery occlusion, blood flow interruption caused by severe and persistent myocardial necrosis caused by ischemia. Hypoxia causes brain tissue necrosis. Ischemia and hypoxia and cardiovascular and cerebrovascular diseases are mutually causal, becoming two evils that affect life. therefore. To treat cardiovascular and ce...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/685A61K9/48A61P9/06A61P9/10A61P9/12A61K31/122A61K31/355
Inventor 林华型
Owner 林华型
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com